Canada markets closed

Aligos Therapeutics, Inc. (ALGS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.7303-0.0462 (-5.95%)
At close: 04:00PM EDT
0.7500 +0.02 (+2.70%)
After hours: 05:16PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
13,792
15,529
13,907
4,359
0
Operating Expenses
Research Development
71,271
73,040
85,077
104,153
79,890
Selling General and Administrative
28,776
30,616
26,410
28,527
17,944
Total Operating Expenses
100,047
103,656
111,487
132,680
97,834
Operating Income or Loss
-86,255
-88,127
-97,580
-128,321
-97,834
Total Other Income/Expenses Net
-
-
-
-
-10,548
Income Before Tax
-98,807
-86,884
-95,940
-128,189
-108,382
Income Tax Expense
780
795
106
143
161
Income from Continuing Operations
-99,587
-87,679
-96,046
-128,332
-108,543
Net Income
-99,587
-87,679
-96,046
-128,332
-108,543
Net Income available to common shareholders
-99,587
-87,679
-96,046
-128,332
-108,543
Basic EPS
-1.89
-
-2.25
-3.22
-10.87
Diluted EPS
-1.89
-
-2.25
-3.22
-10.87
Basic Average Shares
43,117
-
42,695
39,855
9,988
Diluted Average Shares
43,117
-
42,695
39,855
9,988